SURG
SurgePays·NASDAQ
--
--(--)
--
--(--)
0.51 / 10
Underperform
SurgePays' fundamental health is concerning: the Asset-MV factor is in group 1 with a 0/3 quality score, Net income-Revenue is in group 2 with a 2/3 score, and Cash-MV is again in group 1 (0/3). Historical back-tests show negative one-month returns for these metrics, underscoring balance-sheet and profitability weaknesses. Although Total profit (YoY) and Net profit attributable to parent company shareholders (YoY) are in group 1, their positive values (+3.37% and +14.31% respectively) are outweighed by the deficits in other areas, leading to an overall fundamental rating of 'Underperform'.
Analysis Checks(3/10)
Revenue-MV
Value0.42
Score0/3
Weight48.06%
1M Return-8.06%
Value0.42
Score0/3
Weight48.06%
1M Return-8.06%
PB-ROE
Value2.94
Score1/3
Weight12.80%
1M Return-2.20%
Value2.94
Score1/3
Weight12.80%
1M Return-2.20%
Net cash flow from operating activities (YoY growth rate %)
Value-32.18
Score0/3
Weight5.08%
1M Return-1.11%
Value-32.18
Score0/3
Weight5.08%
1M Return-1.11%
Asset-MV
Value-0.51
Score0/3
Weight12.02%
1M Return-2.29%
Value-0.51
Score0/3
Weight12.02%
1M Return-2.29%
Inventory turnover days
Value10.20
Score3/3
Weight-12.93%
1M Return2.04%
Value10.20
Score3/3
Weight-12.93%
1M Return2.04%
Net income-Revenue
Value-0.15
Score2/3
Weight-20.99%
1M Return3.63%
Value-0.15
Score2/3
Weight-20.99%
1M Return3.63%
Total profit (YoY growth rate %)
Value3.37
Score2/3
Weight3.19%
1M Return-0.65%
Value3.37
Score2/3
Weight3.19%
1M Return-0.65%
Cash-UP
Value-0.05
Score0/3
Weight35.24%
1M Return-11.97%
Value-0.05
Score0/3
Weight35.24%
1M Return-11.97%
Net profit attributable to parent company shareholders (YoY growth rate %)
Value14.31
Score1/3
Weight1.71%
1M Return-0.34%
Value14.31
Score1/3
Weight1.71%
1M Return-0.34%
Cash-MV
Value-0.07
Score0/3
Weight15.82%
1M Return-2.63%
Value-0.07
Score0/3
Weight15.82%
1M Return-2.63%
Revenue-MV
Value0.42
Score0/3
Weight48.06%
1M Return-8.06%
Value0.42
Score0/3
Weight48.06%
1M Return-8.06%
Net income-Revenue
Value-0.15
Score2/3
Weight-20.99%
1M Return3.63%
Value-0.15
Score2/3
Weight-20.99%
1M Return3.63%
PB-ROE
Value2.94
Score1/3
Weight12.80%
1M Return-2.20%
Value2.94
Score1/3
Weight12.80%
1M Return-2.20%
Total profit (YoY growth rate %)
Value3.37
Score2/3
Weight3.19%
1M Return-0.65%
Value3.37
Score2/3
Weight3.19%
1M Return-0.65%
Net cash flow from operating activities (YoY growth rate %)
Value-32.18
Score0/3
Weight5.08%
1M Return-1.11%
Value-32.18
Score0/3
Weight5.08%
1M Return-1.11%
Cash-UP
Value-0.05
Score0/3
Weight35.24%
1M Return-11.97%
Value-0.05
Score0/3
Weight35.24%
1M Return-11.97%
Asset-MV
Value-0.51
Score0/3
Weight12.02%
1M Return-2.29%
Value-0.51
Score0/3
Weight12.02%
1M Return-2.29%
Net profit attributable to parent company shareholders (YoY growth rate %)
Value14.31
Score1/3
Weight1.71%
1M Return-0.34%
Value14.31
Score1/3
Weight1.71%
1M Return-0.34%
Inventory turnover days
Value10.20
Score3/3
Weight-12.93%
1M Return2.04%
Value10.20
Score3/3
Weight-12.93%
1M Return2.04%
Cash-MV
Value-0.07
Score0/3
Weight15.82%
1M Return-2.63%
Value-0.07
Score0/3
Weight15.82%
1M Return-2.63%
Is SURG undervalued or overvalued?
- SURG scores 0.51/10 on fundamentals and holds a Premium valuation at present. Backed by its -502.58% ROE, -83.76% net margin, -0.48 P/E ratio, -3.61 P/B ratio, and -83.62% earnings growth, these metrics solidify its Underperform investment rating.
